API
Intermediates
Custom synthesis
Polypetides
Nucleotide series
 Apixaban |
| Aprepitant |
| Bepotastine besylate |
| Bisoprolol Fumarate |
| Clomifene Citrate |
| Cyclophosphamide |
| Darifenacin HBr |
| Dronedarone Base |
| Dronedarone Hydrochloride |
| Dasatinib |
| Dasatinib monohydrate |
| Deferasirox |
| Febuxostat |
| Fesoterodine fumarate |
| Ivabradine Hydrochloride |
| Indacaterol |
| Lafutidine |
| Leucovorin Calcium |
| L-Leucovorin Calcium |
| Methotrexate |
| Mizolastine |
| Olopatadine Hydrochloride |
| Prasugrel Hydrochloride |
| Prasugrel base |
| Paricalcitol |
| Rivaroxaban |
| Silodoxin |
| Tamoxifen Citrate |
| Voriconazole |
| Voglibose |
| Calcitonin |
| Desmopressin |
| Terlipressin |
| Enfuvirtide(T-20) |
| Eptifibatide |
| Glucagon |
| Gonadorelin |
| Goserelin |
| Hexarelin |
| Leuprorelin |
| MelanotanⅡ |
| Octreotide |
| Sermorelin |
| Somatostatin |
| Thymopentin |
| α1Thymosin alpha-1 |
| Triptorelin |
| Buserelin |
| Deslorelin |
| Fertirelin |
| Nafarelin |
| Alarelin |
| Histrelin |
| Bivalirudin |
| Nesiritide |
| Exenatide |
| Pramlintide |
| Liraglutide |
| 1H-Inden-2-amine,5,6-diethyl-2,3-dihydro-,hydrochloride (1:1) |
| 4-(4-Aminophenyl)morpholin-3-one(For Ivabradine) |
| (S)-N-(2, 3-Epoxypropyl)phthalimide(For Ivabradine) |
| 3,4-dimethoxy-N-methyl-bicyclo[4.2.0]octa-1,3,5-triene-7-methanamine hydrochloride (For Ivabradine) |
| 3-(3-chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-Benzazepin-2-one(For Ivabradine) |
| Methanone, (2-butyl-5-nitro-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl](For Dronedarone) |
| (5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]-methanone dioxalate(For Dronedarone) |
| 2-Butyl-3-(4-methoxybenzoyl)-5-nitrobenzofuran(For Dronedarone) |
| 2-(n-Butyl)-3-(4-hydroxybenzoyl)-5-nitrobenzofuran(For Dronedarone) |
| N-(3-Chloropropyl)dibutylamine(For Dronedarone) |
| Ethyl 4-[(4-chlorophenyl)-2-pyridinylmethoxy]-1-piperidinecarboxylate(For Bepotastine) |
| 2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]-pyridine(For Bepotastine) |
| 2-[(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine 4-nitrobenzoate |
| 6-ethyl-5-fluoro-4-hydroxypyrimidine(For Voriconazole) |
| 4-chloro-6-ethyl-5-fluoropyrimidine(For Voriconazole) |
| (2R,3S/2S,3R)-3-(4-Chloro-5-fluoro-6-pyrimidinyl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol hydrochloride (For Voriconazole) |
| (2R,3S/2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (Racemic Voriconazole) |
| 4-[(2-carboxyphenyl)methoxy]benzeneacetic acid (For Olopatadine) |
| 6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid(For Olopatadine) |
| [3-(dimethylamino)propyl]triphenylphosphonium bromide hydrobromide (For Olopatadine) |
| N-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}phthalimide Maleate(For Lafutidine) |
| 2-Chloro-4-(piperidin-1-ylmethyl)pyridine Oxalate(For Lafutidine) |
| p-nitrophenyl 2-(furfurylsulfinyl)acetate(For Lafutidine) |
| 5,6,7,8-tetrahydro-2-naphthol(For Liranaftate) |
| 2,3-dihydrobenzofuranyl-5-acetic acid(For Darifenacin) |
| 5-(2-bromoethyl)-2,3-dihydrobenzofuran (For Darifenacin) |
| (s)-2,2-diphenyl-2-(1-tosylpyrrolidin-3-yl)acetonitrile(For Darifenacin) |
| 2,2-Diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide L-(+)-tartrate (For Darifenacin) |
| Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl-5-Thiazolecarboxylate(For Febuxostat) |
| Ethyl 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-Thiazolecarboxylate(For Febuxostat) |
| KRP-203，2-Amino-2-(2-(4-(3-benzyloxyphenylthio)-2-chlorophenyl)ethyl)-1,3-propanediol hydrochloride |
| 1H-Indole-7-boronic acid |
| 38. 2-(Chloromethyl)-3-(trifluoromethyl)pyridine |
| Aromadendrin |
| Diphenyleneiodonium Sulfate |
| Ethyl 4-bromothiazole-2-carboxylate |
| 1-(2-Methylpyrimidin-5-yl)ethanamine |
| 3-Chloromethyl-1,2,4-oxadiazole |
| 5-Chloropyrazine-2-carbaldehyde |
| 2,3-Pyridinedicarboxylicacid,4-amino-,dimethylester |
| Methyl 3-amino-5,6-dimethylpyrazine-2-carboxylate |
| Ethyl 3-amino-4-methoxythieno[2,3-b]pyridine-2-carboxylate |
| Ethyl 3-amino-5-nitrothieno[2,3-b]pyridine-2-carboxylate |
| 1-(5-Methylpyrimidin-2-yl)ethanol |
| 7-Chloro-5-methoxy-Thieno[3,2-b]pyridine |
| 2-Bromo-7-chloro-thieno[3,2-b]pyridine |
| 5-Bromo-2,3-dihydro-1H-inden-2-ol |
| 5,7-Dichloro-pyrido[4,3-d]pyrimidin-4(3H)-one |
| 3-Bromo-5-methyl-1H-pyrazole |
| Lumiracoxib |
| Asenapine |
| Lurasidone |
| Lurasidone |
| Lurasidone HCl |
| Posaconazole |
| Alvimopan |
| Rivastigmine tartrate |
| Rasagiline mesylate |
| H-L-Asu-OH |
| 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate(for Silodoxin) |
| 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate(for Silodoxin) |
| Cyclopropyl-2-fluorobenzyl ketone (for Prasugrel) |
| 5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one 4-methylbenzenesulfonate (for Prasugrel) |
| 5,6,7,7a-Tetrahydro-5-(triphenylmethyl)thieno[3,2-c]pyridinone(for Prasugrel) |
| 4-(2-Hydroxyethyl)oxyindole(forRopinirole) |
| 2,3,4,6-Tetra-O-benzyl-alpha-D-glucose (forVoglibose) |
| Tetrabenzyl-voglibose(forVoglibose) |
| 4,5-Dimethoxy-1-cyanobenzocyclobutane |
| (S)-4-[1-(4-Chlorophenyl)-1-(2-pyridyl) methoxy] piperidine (For Bepotastine) |
| Landiolol HCl |
| ((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-hydroxyphenyl)propanoate |
| (S)-(+)-Glycidyl nosylate |
| N-(2-Aminoethyl)-4-morpholinecarboxamide ethanedioate |
| methotrexate disodium |
| 2,4,5,6-Tetraaminopyrimidine sulfate |
| 2,4-diamino-6-(bromomethyl)pteridine |
| 2,3,4,6-Tetra-O-benzyl-D-glucopyranose(for Voglibose) |
| 8-benzyloxy-5-(2-bromoacetyl)-2-(1H)-quinolinone) (for indacaterol) |
| (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione(for Lurasidone) |
| (3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine(for Alvimopan) |
| (alphaS,3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethyl-alpha-(phenylmethyl)-1-piperidinepropanoic acid methyl ester(for Alvimopan ) |
| (R)-2-Benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoic acid(for Alvimopan) |
| Entecavir |
| 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine (For Bepotastine) |
| (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester |
| 2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one |
| Pidotimod |
| Raltitrexed |
| Pemetrexed disodium |
| olmesartan medoxomil |
| Doxofylline |
| Anagrelide Hydrochloride |
| Anagrelide |
| pramipexole dihydrochloride |
| Trans-(+/-)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-1-one |
| 11-chloro-2,3-dihydro-2-methyl-1H-dibenz[2,3;6,7]oxepino[4,5-c]pyrrol-1-one |
| (5-Chloro-2-phenoxyphenyl)acetic acid |
| Trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
| Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
| Mixture of Trans and Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
| 5-Chloro-2-Methyl-2,3-Dihydro-Benzo-[2,3:6,7]-Oxepino-[4,5-C]-pyrrole-(2H)-One |
| Dabigatran etexilate mesylate |
| Dabigatran etexilate |
| 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester |
| N-(4-Cyanophenyl)glycine |
| Benzoic acid, 4-(methylamino)-3-nitro |
| Ethyl 3-(pyridin-2-ylamino)propanoate |
| 2-(4-Methoxy-1,4-cyclohexadienyl)-2-propanol(for Nabilone) |
| 5-(1,1-Dimethylheptyl)resorcinol(for Nabilone) |
| 2-Hydroxyquinoline-4-carboxylic acid |
| Tetraisopropyl methylenediphosphonate(for Disodium clodronate) |
| Di(N-succinimidyl) adipate |
| TRI(ETHYLENE GLYCOL) DI-P-TOLUENESULFONATE |
| (S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate |
| 5-[(2R,S)-2-AMINOPROPYL]-1-[3-(BENZOYLOXY)PROPYL]-2,3-DIHYDRO-1H-INDOLE-7-CARBONITRILE |
| (R)-tetrahydrothiophen-3-ol |
| ethyl 4-(4-hydroxypiperidin-1-yl) butanoate |
| (S)-(4-chlorophenyl)(pyridine-2yl)methanol (S form) |
| ethyl 4-(4-bromoypiperidin-1-yl)butanoate |
| Benzothiophene-3-carboxylic acid |
| Edoxaban tosylate monohydrate |
| Edoxaban |
| 4,5,6,7-tetrahydro-5-Methyl-Thiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride |
| Carbamic acid, N-[(1R,2S,5S)-2-[[2-[(5-chloro-2-pyridinyl) amino]-2-oxoacetyl]amino]-5-[(dimethylamino)carbonyl]cyclohexyl]-, 1,1-dimethylethyl ester |
| Carbamic acid,[(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]-,1,1-dimethylethyl ester |
| N-[3-fluoro-4-[(methylamino)carbonyl]phenyl]-2-methyl-alanine |
| N-[3-fluoro-4-[(methylamino)carbonyl]phenyl]-2-methyl-alanine methyl ester |
| 4-Isothiocyanato-2-(trifluoromethyl)benzonitrile |
| Enzalutamide |
| Naphthalene,1-cyclopropyl-4-isothiocyanato- |
| THR-PHE-GLN-ALA-TYR-PRO-LEU-ARG-GLU-ALA |
| esinurad |
| (R)-3-aminobutan-1-ol |
| 1533519-85-5 |
| Apremilast |
| N-(1,3-dioxo-1,3-dihydro-isobenzofuran-4-yl)acetamide |
| 4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione |
| Acotiamide hydrochloride |
| 138530-94-6 |
| MK-4305 |
| FYX 051 |
| 6-Ethylchenodeoxycholic acid |
|
We have broad based research efforts spanning across a number of therapeutic areas.
Eagle Sky PharmaTech is currently pursuing research programs in the following principal areas: cardiovascular and diabetes. In all of these programs, we have identified targets and compounds with demonstrated in vitro and, in some cases, in vivo activity.
Utilizing our proprietary know-how and integrated scientific and drug development capabilities, we have identified multiple drug candidates.
Eagle Sky PharmaTech is conducting clinical and preclinical studies in its core focus areas, which include the following:
· 胆固醇异常
ESP-8509 recently completed 近期已经完成先导药物的筛选及化学合成。
· Renin inhibitors 肾素抑制剂
ESP-9085 recently completed target identification and design. 近期已完成了药物靶点的识别，先导药物的筛选及化学合成及设计.
·DPPIV inhibitors 二肽基肽酶抑制剂
ESP-8012 completed target identification, screening, lead modification, SAR, in-vitro studies.
Applied China and US patent.
ESP-8012 完成了药物靶点的识别，先导化合物的筛选及修饰，体外实验的安全分析报告。
In addition to the areas noted above, Eagle Sky PharmaTech is continuing to explore the human genome to identify new therapeutic opportunities.
除了上述所述领域，我公司还在继续探究人体基因组，以发现出新的治疗途径和机会。
|
